Through our Fellowship scheme, we invite applications for Post-doctoral fellowships and Clinical PhD fellowships from candidates seeking to conduct their own independent research, focused on on one of our three research themes.
This year's call is now open, with an application deadline of 14th January 2026. Awards are expected to be made in May 2026.
Fellowship applications must be based on a research proposal that addresses an area of large unmet need within one of our three research themes:
Research proposals must be based on either:
We invite applications from individuals working in one of our three priority research areas, who wish to conduct their own independent research within a UK host laboratory.
Post-doctoral fellowships will be for three-years, or part-time equivalent (minimum 0.5 FTE, maximum duration six years), with a maximum value of £300,000, including salary and research costs.
We invite applications from medical doctors with ambition to follow a clinical academic career, and who are at an appropriate point in clinical training to study for a PhD.
Clinical PhD fellowships will be for a minimum of two and maximum of four years, with a maximum value of £300,000, including salary, fees and research costs.
The maximum award is £300,000, including salary at the appropriate grade and scale, and direct research and training costs, including PhD fees for clinical candidates.
We expect the salary funding to cover the salary of the applicant in its entirety for the duration of the Fellowship; we will not part-fund a salary at a higher level.
For clinical applicants, we will provide a salary appropriate to your level of training, up to but not including NHS consultant level. We will pay tuition fees at the standard home student rate.
Exclusions:
BRUK is mission-driven. Proposals must show:
Direct relevance to a specific neurological illness
Clear potential to improve understanding, diagnosis, therapy, or quality of life
Connection to disease burden in the UK
Predictor: The disease-focused rationale is explicit, compelling, and patient-centred.
BRUK highly values projects that bridge basic discoveries to clinical impact.
Competitive applications often:
Address clinical unmet needs
Include biomarkers, therapeutic leads, or treatment-target identification
Provide a clear plan for translation into future clinical trials or interventions
Involve patient cohorts or clinically relevant models
Predictor: Clear “line of sight” from lab → patient benefit.
Given BRUK grants are often early-stage or mid-scale:
1–3 focused aims = ideal
Realistic deliverables within 12–36 months
A robust methodological plan with appropriate controls
Strong statistical and reproducibility framework
Overly ambitious scope is a frequent reason for rejection.
Projects with:
Pilot results
Feasibility demonstrations
Proof-of-concept outcomes
…tend to score higher, especially when proposing translational or therapeutic work.
Early-career awards may permit less data but require strong rationale.
Predictor: Evidence that the proposed work is ready to progress.
BRUK reviewers look for:
Institutional infrastructure (neuroscience centres, clinical access, core facilities)
Multi-disciplinary teams (neurologists, neurosurgeons, neuroscientists, imaging, computational scientists)
Access to patient cohorts, tissue banks, imaging labs, or animal facilities
Strong mentorship for early-career applicants
Predictor: Demonstrated capacity to deliver — not just a good idea.
For senior PIs:
Demonstrated productivity
Prior successful grants
Publications in relevant fields
For early-career researchers:
Clear trajectory toward independence
Supportive mentorship environment
Thoughtful career development plan
Predictor: A credible team with a record (or strong promise) of high-quality neuroscience work.
Increasingly important:
Involvement of patients/carers in proposal design or dissemination
Impact statements explaining how outcomes matter to real people
Public engagement plans
Predictor: Strong “PPIE” (Patient and Public Involvement and Engagement) boosts competitiveness.
BRUK positions itself as a springboard to major funders.
Winning proposals typically state:
How results will underpin applications to UKRI, NIHR, Wellcome, or other charities
A long-term vision beyond the project term
Plans for multi-centre trials, translational pipelines, or therapeutic development
Predictor: Convincing scalability + strategy for external follow-on funding.
| Pitfall | Why It Hurts |
|---|---|
| Weak linkage to a specific neurological disorder | Lack of mission alignment |
| Overly ambitious scope | Reviewers doubt feasibility |
| Minimal preliminary data for high-risk projects | Too speculative |
| Poor statistical/experimental detail | Methodological risk |
| No translational pathway | Low patient-impact value |
| Lack of PPIE or public benefit justification | Fails to meet modern expectations |
| Weak institutional support | Execution risk |
Post-doctoral fellowships
Clinical PhD fellowships
Sponsor Institute/Organizations: Brain Research UK
Sponsor Type: Corporate/Non-Profit
Address: Fifth Floor, Holborn Gate, 330 High Holborn, London WC1V 7QH.
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 14, 2026
Jan 14, 2026
$399,000
Affiliation: Brain Research UK
Address: Fifth Floor, Holborn Gate, 330 High Holborn, London WC1V 7QH.
Website URL: https://www.brainresearchuk.org.uk/research/apply/fellowship
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.